Topical Ethylenediaminetetraacetic acid (EDTA) administration following corneal diamond burr keratotomy for calcareous corneal degeneration in canines

Vet Ophthalmol. 2022 May;25(3):225-231. doi: 10.1111/vop.12969. Epub 2022 Jan 10.

Abstract

Objective: To evaluate the outcomes of canine patients diagnosed with corneal ulceration associated with presumed calcareous corneal degeneration (CCD) that were treated with diamond burr keratotomy (DBK) and ongoing postoperative topical 3% or 4% Ethylenediaminetetraacetic acid (EDTA).

Procedures: Retrospective assessment of CCD cases treated with ongoing topical EDTA following DBK between 2011 and 2020 at Veterinary Ophthalmic Referrals. Descriptive statistics of the study population were assessed, and a survival analysis was performed using R statistical software.

Results: A total of 51 eyes from 41 dogs were assessed, with small terrier breeds overrepresented (27/41, 65.9%). Median age of dogs at the time of diagnosis was 14.3 years (range 8-17.2 years). Following DBK, the median time to commencement of topical EDTA was 11 days (range 0-28 days). Cases were followed for a median duration of 216 days (range 42-1379 days). Corneal ulceration recurred in 7/51 (13.7%) eyes at a median duration of 80 days (range 63-156 days). The probability of recurrence of corneal ulceration associated with CCD at 12 months was 15.6% (95% CI: 4.1-25.7%). A second DBK procedure followed by ongoing topical EDTA was performed in 4/7 (57.1%) of the recurred eyes. These retreated eyes had no further recurrence recorded and a median follow-up time of 401 days (range 120-858 days).

Conclusion: Ongoing topical EDTA following DBK is an effective adjunct treatment method for CCD with reduced rates of recurrence of CCD-associated corneal ulceration when compared to published rates of recurrence when treated with DBK alone.

Keywords: calcareous corneal degeneration (CCD); canine; corneal ulceration; diamond burr keratotomy (DBK); ethylenediaminetetraacetic acid (EDTA); recurrence.

MeSH terms

  • Administration, Topical
  • Animals
  • Calcinosis* / veterinary
  • Cornea / surgery
  • Corneal Dystrophies, Hereditary* / surgery
  • Corneal Dystrophies, Hereditary* / veterinary
  • Corneal Ulcer* / drug therapy
  • Corneal Ulcer* / surgery
  • Corneal Ulcer* / veterinary
  • Debridement / veterinary
  • Dog Diseases* / drug therapy
  • Dog Diseases* / surgery
  • Dogs
  • Edetic Acid / therapeutic use
  • Retrospective Studies

Substances

  • Edetic Acid